$LLY News

Dow Jones Futures: Market Rebounds, Now Watch For This; SpaceX, AMD, Sandisk, Eli Lilly Earnings Loom

Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.

Jim Cramer says one popular stock is meant to be owned, not traded

Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said.

Weight Loss Drug Stocks Novo Nordisk, Eli Lilly Slump Below Key Levels

The Signs Before Eli Lilly Stock Surged Were All On The Record

LLY Stock: Collect 12% Now, In Exchange For Capping Upside At 15%

Lilly (LLY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Resilience and Lilly to increase US medicines production with $750m investment

Lilly Boosts Diabetes and Obesity Capacity With $750 Million Deal

Eli Lilly (LLY) Joins Illumina’s Billion Cell Atlas For AI Drug Discovery

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma

Eli Lilly, Resilience Investing $750M To Expand Critical Medicines Manufacturing ​Capacity In U.S.

How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q2 Results?

Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?

Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth